Edition:
United States

People: Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

65.93USD
23 Apr 2019
Change (% chg)

$2.45 (+3.86%)
Prev Close
$63.48
Open
$63.77
Day's High
$66.25
Day's Low
$62.94
Volume
210,467
Avg. Vol
153,514
52-wk High
$91.03
52-wk Low
$31.13

Cohen, Fred 

Dr. Fred E. Cohen, Ph.D. M.D., serves as Independent Director of the Company. Dr. Baker’s firm manages long-term investment funds, focused on publicly traded life sciences companies, for major university endowments and foundations. Dr. Baker’s career as a fund-manager began in 1994 when he and his brother co-founded a biotechnology investing partnership with the Tisch Family. Dr. Baker is also a director of Seattle Genetics, Inc., where he serves as lead independent director, and Alexion Pharmaceuticals, Inc. Dr. Baker served as a director of Synageva BioPharma Corp. from October 2000 until its acquisition in June 2015. Dr. Baker holds a B.S. and Ph.D. in Immunology from Stanford University, where he also completed two years of medical school.

Basic Compensation

Total Annual Compensation, USD 15,250
Restricted Stock Awards, USD 40,000
Long-Term Incentive Plans, USD --
All Other, USD 132,727
Fiscal Year Total, USD 187,977

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kimberly Popovits

4,117,300

Gordon Cole

1,606,770

Steven Shak

1,418,200

Phillip Febbo

--

Laura Kammeyer

--

Frederic Pla

1,588,330
As Of  30 Dec 2017